By bodil [dot] malmstrom [at] fsi [dot] lu [dot] se (Bodil Malmström) - published 25 March 2021 Cancer in the colon and rectum is the third most common form of cancer after prostate and breast cancer. This screening will help healthcare providers to detect colorectal cancer at an early stage In May, screening for colorectal cancer will be offered in Skåne to all those born in 1961. Subsequently, S

https://www.lucc.lu.se/article/screening-colorectal-cancer-starts-spring - 2025-03-11

Published 4 May 2021 3D-mammography, to the right, gives a more detailed image 3D-mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology. “Our results indicate that 3D-mammography, or digital bre

https://www.lucc.lu.se/article/fewer-breast-cancer-cases-between-screening-rounds-3d-mammography - 2025-03-11

Published 4 May 2021 Sergii Gladchuk, Anthony George, Malin Dahlgren, Christian Brueffer, Lao Saal and Yilun Chen. (Photo: Olle Dahlbäck) A small proportion of women who receive anti-estrogen treatment after breast cancer surgery have worse outcomes. This is associated with mutations in the estrogen receptor gene, according to a study from Lund University now published in JNCI Cancer Spectrum.   “

https://www.lucc.lu.se/article/mutations-can-reduce-effect-hormonal-treatment-early-breast-cancer - 2025-03-11

Published 24 May 2021 Pia Sundgren has been elected as Senior Fellow of the International Society of Magnetic Resonance in Medicine (ISMRM) and Titti Owman recieved Distinguished Service Award from the Society for MR Radiographers & Technologist (SMRT). Pia C. Maly Sundgren, M.D., Ph.D., Lund University, Lund, Sweden has been elected as Senior Fellow of the International Society of Magnetic Resona

https://www.lucc.lu.se/article/elected-senior-fellow-and-distinguished-service-award-lund - 2025-03-11

Published 28 June 2021 Skåne University Hospital is in a process to establish a Comprehensive Cancer Centre. A digital site visit by the Organisation of European Cancer Institutes (OECI) took place 22-24 June, 2021 as part of the accreditation process to establish a Comprehensive Cancer Centre at Skåne University Hospital. OECI has an accreditation programme to implement quality in cancer care. Sk

https://www.lucc.lu.se/article/accreditation-process-improve-cancer-care-skane-university-hospital - 2025-03-11

Published 30 September 2021 Photo: Tove Smeds Congratulations Anna Blom, Professor of Medical Protein Chemistry at Lund University and the recipient of the Swedish Society of Medicine’s Berzelius Medal in Gold 2021 for innovative research in the field of medical chemistry. How does it feel to receive this prestigious award? – It’s a great honour for me to be awarded the Berzelius Medal and for our

https://www.lucc.lu.se/article/anna-blom-receives-2021-berzelius-medal-advances-medical-chemistry - 2025-03-11

Published 20 October 2021 Information about the Advanced Cancer Biology course VMFN29 (30 ECTS) can be found here The application period is from October 18th 2021 to January 17rd 2023 and you apply in the international admission portal The course period is from August 29th 2022 to January 23rd 2023.  

https://www.lucc.lu.se/article/international-admission-advanced-cancer-biology-course-open - 2025-03-11

Published 17 December 2021 After a major development work where researchers and experts in urology, communication and IT have collaborated, Region Skåne landed Organized prostate cancer testing, OPT, 2020. Photo: iStockphoto With 10,000 new cases a year, prostate cancer is the most common cancer type in Sweden. To create equal, accessible and high-quality prostate cancer care, Region Skåne has int

https://www.lucc.lu.se/article/organised-prostate-cancer-testing-provide-more-equal-care - 2025-03-11

Published 7 March 2022 Göran Jönsson, Professor in molecular oncology at Lund University. Photo: Tove Smeds Congratulations to Göran Jönsson who receives this year's Göran Gustafsson Prize in medicine. The prize is awarded by the Royal Academy of Sciences and is awarded to younger researchers who have achieved great success in their field. Göran Jönsson, professor in molecular oncology at Lund Uni

https://www.lucc.lu.se/article/goran-jonsson-receives-goran-gustafssons-prize-medicine-groundbreaking-research-immunotherapy-cancer - 2025-03-11

Published 18 March 2022 Alexander Pietras, Associate Professor at Lund University, have been awarded an European Research Council Consolidator Grant (ERC-CoG) for the project - RESISTANCEPROGRAMS. The research group will explore and exploite the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors. Glioblastoma multiforme (GBM), the deadliest form of bra

https://www.lucc.lu.se/article/euroupean-research-council-consolidator-grant-alexander-pietras - 2025-03-11

Published 12 April 2022 istock/selvanegra In a recent study from Lund University in Sweden, researchers discovered that metabolic changes affect how blood cells are formed during embryonic development. They found a previously unknown metabolic switch with a key role in how different types of blood cells develop. This means blood cell formation can be directed towards producing natural killer cells

https://www.lucc.lu.se/article/metabolism-found-regulate-production-killer-cells - 2025-03-11

Published 13 April 2022 iStock/Design cells In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionised areas of cancer care. However, there are still significant challenges in the identification of cancer cell surface proteins as ta

https://www.lucc.lu.se/article/new-precision-technology-immunotherapy - 2025-03-11

Published 11 May 2022 Smokers have a lower risk of developing prostate cancer, but a higher risk of dying from the disease, according to a large population study led by Lund University in Sweden. The researchers followed more than 350 000 people over several decades, and the results are now published in European Urology. It is well known that smokers have an increased risk of developing various ca

https://www.lucc.lu.se/article/smoking-worsens-prognosis-men-prostate-cancer - 2025-03-11

Published 15 May 2022 Skåne University Hospital Cancer Centre (SUHCC) has been accredited as Comprehensive Cancer Centre (CCC) by the Organisation of European Cancer Institutes (OECI). The accreditation as Comprehensive Cancer Centre means that an organisation has been approved according to the highly set quality criteria of the Organisation of European Cancer Institutes (OECI). Skåne University H

https://www.lucc.lu.se/article/skane-university-hospital-cancer-centre-accredited-comprehensive-cancer-centre - 2025-03-11

Published 15 June 2022 Paul Bourgine, Researcher and Wallenberg Fellow in Molecular Medicine. Photo: Kennet Ruona. By using cells isolated from cancer patients and mixing them with a new technology called “OssiGel”, it is possible to engineer human mini-bones. These miniaturized organs consist of mature bone and marrow tissue and can be used as model to study the disease mechanisms behind cancers

https://www.lucc.lu.se/article/miniature-bones-research-model-cancer - 2025-03-11

Published 25 August 2022 Photo: iStock/33karen33 The environment in which breast cancer arises –the interplay between the patient’s BMI, tumour size and cancer-specific proteins –is of importance for the prognosis. This is shown in a study from Lund University in Sweden. The knowledge could further enhance precision medicine in breast cancer. Major advances in diagnostics and treatment have improv

https://www.lucc.lu.se/article/tumour-environment-can-affect-breast-cancer-prognosis - 2025-03-11

Published 21 October 2022 Illustration of T cell attack on cancer cell. Illustration: iStock/luismmoling Göran Jönsson, professor of molecular oncology, receives SEK 31 million from the Knut and Alice Wallenberg Foundation to enhance the effect of immunotherapy in the treatment of cancer patients. About 30 per cent of patients with metastatic melanoma benefit from immunotherapy. At the same time,

https://www.lucc.lu.se/article/sek-31-million-enhance-effect-immunotherapy-treatment-cancer-patients - 2025-03-11

Published 15 November 2022 Photo: iStock/kan2d Researchers at Lund University in Sweden have identified one of the reasons why the childhood cancer neuroblastoma becomes resistant to chemotherapy. The findings are significant for how future treatments should be designed. The results have been published in Science Advances. Neuroblastoma is an aggressive cancer of the sympathetic nervous system, es

https://www.lucc.lu.se/article/altered-cell-behaviour-behind-resistance-neuroblastoma - 2025-03-11

Published 13 February 2023 Johan Flygare and Aurélie Baudet, stem cell researchers at Lund University. Photo: Johan Persson. Stem cells programmed to produce insulin in people with type 1 diabetes or to repair the heart muscle after a heart attack. Gene and cell therapies that improve cancer treatments. These new and innovative therapies have the potential to cure, alleviate and treat diseases whe

https://www.lucc.lu.se/article/advanced-treatments-future-are-soon-here - 2025-03-11

Published 13 February 2023 Dolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples of cellular programming sparked his curiosity about the human body. Photo: Johan Persson By reprogramming tumour cells to become the body’s defenders, Filipe Pereira and his colleagues hope to improve curren

https://www.lucc.lu.se/article/reprogramming-cancer-cells-immune-defenders - 2025-03-11